Amar Ahmad
Research Scientist / Biostatistician
Affiliation: NYU Abu Dhabi
Education: German Diplom University of Munich (LMU); PhD University of Munich (LMU)
Research Areas: Application of statistics in medical research; Multivariate statistical strategies for data mining; Clinical trial design; Pragmatic clinical trial; Cancer Research
Amar Ahmad began working as a Principal Statistician at CRUK (Cancer Research UK) in October 2018. In addition to this role, he holds a Ph.D. in Statistics from the University of Munich (Ludwig Maximilian University), which he obtained in 2007. Amar also completed a German Diplom in Statistics at the same university in 2003, equivalent to earning both U.S. Bachelor's and Master's degrees. He is a fellow of the Royal Statistical Society and Advance HE in the UK.
Over the past two decades, Amar has dedicated his career to biostatistics. He started as a research assistant at the University of Munich in 2003, and later in 2007, he delved into the statistical analysis of clinical trial methodology at Bayer Pharmaceuticals in Berlin, Germany.
In 2009, he transitioned to London University, initially at the Institute of Cancer Research and later in 2010 at Queen Mary University of London. His research publication, "Trends in the lifetime risk of developing cancer in Great Britain: comparison of risk for those born from 1930 to 1960. Ahmad et al. (2015). Br J Cancer," was recognized as the paper of the year in Cancer Prevention by The Scottish Cancer Prevention Network.
Furthermore, in 2010, Amar was honored with the Jeramy Jass Prize for Research Excellence in Pathology by his colleagues. Currently, Amar Ahmad serves as StatsLab manager and Research Scientist and at New York University Abu Dhabi in the United Arab Emirates.